SHILPA MEDICARE
|
SHILPA MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.01 | 3.67 | -3.74 | 6.99 | 18.13 |
| CEPS(Rs) | 19.56 | 16.11 | 7.44 | 16.17 | 24.55 |
| DPS(Rs) | 1.00 | - | - | 1.10 | 1.10 |
| Book NAV/Share(Rs) | 242.58 | 208.37 | 205.44 | 209.93 | 181.37 |
| Tax Rate(%) | 36.00 | 41.19 | 19.24 | 40.76 | 25.04 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.63 | 20.45 | 8.41 | 17.21 | 19.05 |
| EBIT Margin(%) | 15.38 | 12.69 | 1.94 | 12.52 | 24.07 |
| Pre Tax Margin(%) | 9.51 | 4.72 | -3.65 | 8.93 | 21.65 |
| PAT Margin (%) | 6.09 | 2.77 | -2.94 | 5.29 | 16.22 |
| Cash Profit Margin (%) | 14.87 | 12.14 | 6.15 | 12.26 | 22.21 |
| Performance Ratios | |||||
| ROA(%) | 2.45 | 1.07 | -1.07 | 2.20 | 6.33 |
| ROE(%) | 3.75 | 1.78 | -1.71 | 3.67 | 10.41 |
| ROCE(%) | 6.94 | 5.49 | 0.80 | 5.94 | 10.73 |
| Asset Turnover(x) | 0.40 | 0.38 | 0.36 | 0.42 | 0.39 |
| Sales/Fixed Asset(x) | 0.64 | 0.61 | 0.59 | 0.73 | 0.75 |
| Working Capital/Sales(x) | 4.13 | 6.30 | -70.52 | 4.16 | 3.28 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.56 | 1.65 | 1.70 | 1.37 | 1.34 |
| Receivable days | 118.16 | 113.53 | 123.51 | 98.75 | 97.28 |
| Inventory Days | 98.29 | 105.35 | 117.32 | 109.68 | 113.34 |
| Payable days | 123.69 | 146.72 | 126.70 | 106.00 | 113.98 |
| Valuation Parameters | |||||
| PER(x) | 82.81 | 125.64 | - | 56.83 | 18.41 |
| PCE(x) | 33.89 | 28.64 | 30.83 | 24.56 | 13.59 |
| Price/Book(x) | 2.73 | 2.21 | 1.12 | 1.89 | 1.84 |
| Yield(%) | 0.15 | - | - | 0.28 | 0.33 |
| EV/Net Sales(x) | 5.47 | 4.26 | 2.63 | 3.57 | 3.82 |
| EV/Core EBITDA(x) | 20.70 | 19.43 | 23.11 | 18.78 | 16.25 |
| EV/EBIT(x) | 35.59 | 33.59 | 135.78 | 28.55 | 15.87 |
| EV/CE(x) | 2.38 | 1.79 | 1.07 | 1.64 | 1.48 |
| M Cap / Sales | 5.04 | 3.48 | 1.90 | 3.01 | 3.02 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 11.71 | 9.66 | -8.33 | 27.12 | -0.75 |
| Core EBITDA Growth(%) | 34.65 | 111.11 | -45.13 | 2.98 | -10.54 |
| EBIT Growth(%) | 35.39 | 617.36 | -85.80 | -33.88 | 12.62 |
| PAT Growth(%) | 145.02 | 203.36 | -151.03 | -58.56 | -5.41 |
| EPS Growth(%) | 118.03 | 198.15 | -153.54 | -61.45 | -5.36 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.25 | 0.52 | 0.45 | 0.37 | 0.57 |
| Current Ratio(x) | 1.46 | 1.26 | 0.98 | 1.45 | 1.47 |
| Quick Ratio(x) | 0.95 | 0.77 | 0.58 | 0.88 | 0.90 |
| Interest Cover(x) | 2.62 | 1.59 | 0.35 | 3.48 | 9.92 |
| Total Debt/Mcap(x) | 0.09 | 0.23 | 0.40 | 0.20 | 0.31 |
Compare Financial Ratios of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹7,186.3 Cr | 3.7% | -0.4% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | 3.7% |
-0.4% |
-12.2% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses
